False Claims Act – Page 14 – Policy & Medicine

Salix Settlement Approved

DOJ Announces Genentech and OSI Pharmaceuticals, LLC Settlement

House Energy and Commerce Ask FDA for Update on Off Label Guidance

Breathing Life into Privilege, and the False Claims Act

Peeling Back the Olympus Onion – The Importance of Culture

Amarin and FDA Off Label Free Speech Settlement

Tenet Healthcare Settlement Offer

CMS Issues Final 60 Day Payment Rule

DOJ Becoming Comfortable With Permitting Truthful, Non-misleading Promotion

Off-label Marketing is “Dead,” Diversion Cases on the Rise